ENCOMPASS HEALTH CORP's ticker is EHC and the CUSIP is 29261A100. A total of 407 filers reported holding ENCOMPASS HEALTH CORP in Q1 2022. The put-call ratio across all filers is 0.39 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $48,820,417 | -26.3% | 726,927 | -25.7% | 0.90% | -24.3% |
| Q2 2023 | $66,241,506 | +14.7% | 978,312 | -8.4% | 1.19% | +8.6% |
| Q1 2023 | $57,764,842 | -2.8% | 1,067,742 | +7.5% | 1.10% | -36.5% |
| Q4 2022 | $59,421,594 | +19.5% | 993,506 | -9.6% | 1.73% | -13.4% |
| Q3 2022 | $49,715,000 | -23.3% | 1,099,171 | -4.9% | 2.00% | -14.0% |
| Q2 2022 | $64,790,000 | -17.5% | 1,155,944 | +4.7% | 2.33% | -3.0% |
| Q1 2022 | $78,538,000 | +48.4% | 1,104,443 | +36.2% | 2.40% | +46.5% |
| Q4 2021 | $52,910,000 | +69.7% | 810,768 | +95.1% | 1.64% | +46.2% |
| Q3 2021 | $31,183,000 | +13.8% | 415,550 | +18.3% | 1.12% | +14.5% |
| Q2 2021 | $27,404,000 | +1.1% | 351,201 | +6.1% | 0.98% | -21.3% |
| Q1 2021 | $27,109,000 | +64.2% | 330,997 | +65.7% | 1.24% | +29.9% |
| Q4 2020 | $16,513,000 | – | 199,697 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Copeland Capital Management, LLC | 569,048 | $28,117,000 | 1.78% |
| Kalos Management, Inc. | 76,118 | $3,761,000 | 1.77% |
| Bridge City Capital, LLC | 30,231 | $1,494,000 | 1.08% |
| DALTON GREINER HARTMAN MAHER & CO | 331,823 | $16,395,000 | 0.86% |
| Horrell Capital Management, Inc. | 28,641 | $1,415,000 | 0.74% |
| Polianta Ltd | 26,600 | $1,314,000 | 0.43% |
| GLOBEFLEX CAPITAL L P | 30,177 | $1,491,000 | 0.42% |
| CARILLON TOWER ADVISERS, INC. | 768,748 | $37,984,000 | 0.40% |
| EAGLE ASSET MANAGEMENT INC | 1,070,271 | $53,001,000 | 0.29% |
| S. R. Schill & Associates | 8,108 | $401,000 | 0.25% |